Cargando…
An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors
In the recent cancer treatment, B-Raf kinase is one of key targets. Nowadays, a group of imidazopyridines as B-Raf kinase inhibitors have been reported. In order to investigate the interaction between this group of inhibitors and B-Raf kinase, molecular docking, molecular dynamic (MD) simulation and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661884/ https://www.ncbi.nlm.nih.gov/pubmed/26580609 http://dx.doi.org/10.3390/ijms161126026 |
_version_ | 1782403067831910400 |
---|---|
author | Xie, Huiding Li, Yupeng Yu, Fang Xie, Xiaoguang Qiu, Kaixiong Fu, Jijun |
author_facet | Xie, Huiding Li, Yupeng Yu, Fang Xie, Xiaoguang Qiu, Kaixiong Fu, Jijun |
author_sort | Xie, Huiding |
collection | PubMed |
description | In the recent cancer treatment, B-Raf kinase is one of key targets. Nowadays, a group of imidazopyridines as B-Raf kinase inhibitors have been reported. In order to investigate the interaction between this group of inhibitors and B-Raf kinase, molecular docking, molecular dynamic (MD) simulation and binding free energy (ΔG(bind)) calculation were performed in this work. Molecular docking was carried out to identify the key residues in the binding site, and MD simulations were performed to determine the detail binding mode. The results obtained from MD simulation reveal that the binding site is stable during the MD simulations, and some hydrogen bonds (H-bonds) in MD simulations are different from H-bonds in the docking mode. Based on the obtained MD trajectories, ΔG(bind) was computed by using Molecular Mechanics Generalized Born Surface Area (MM-GBSA), and the obtained energies are consistent with the activities. An energetic analysis reveals that both electrostatic and van der Waals contributions are important to ΔG(bind), and the unfavorable polar solvation contribution results in the instability of the inhibitor with the lowest activity. These results are expected to understand the binding between B-Raf and imidazopyridines and provide some useful information to design potential B-Raf inhibitors. |
format | Online Article Text |
id | pubmed-4661884 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-46618842015-12-10 An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors Xie, Huiding Li, Yupeng Yu, Fang Xie, Xiaoguang Qiu, Kaixiong Fu, Jijun Int J Mol Sci Article In the recent cancer treatment, B-Raf kinase is one of key targets. Nowadays, a group of imidazopyridines as B-Raf kinase inhibitors have been reported. In order to investigate the interaction between this group of inhibitors and B-Raf kinase, molecular docking, molecular dynamic (MD) simulation and binding free energy (ΔG(bind)) calculation were performed in this work. Molecular docking was carried out to identify the key residues in the binding site, and MD simulations were performed to determine the detail binding mode. The results obtained from MD simulation reveal that the binding site is stable during the MD simulations, and some hydrogen bonds (H-bonds) in MD simulations are different from H-bonds in the docking mode. Based on the obtained MD trajectories, ΔG(bind) was computed by using Molecular Mechanics Generalized Born Surface Area (MM-GBSA), and the obtained energies are consistent with the activities. An energetic analysis reveals that both electrostatic and van der Waals contributions are important to ΔG(bind), and the unfavorable polar solvation contribution results in the instability of the inhibitor with the lowest activity. These results are expected to understand the binding between B-Raf and imidazopyridines and provide some useful information to design potential B-Raf inhibitors. MDPI 2015-11-16 /pmc/articles/PMC4661884/ /pubmed/26580609 http://dx.doi.org/10.3390/ijms161126026 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Xie, Huiding Li, Yupeng Yu, Fang Xie, Xiaoguang Qiu, Kaixiong Fu, Jijun An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors |
title | An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors |
title_full | An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors |
title_fullStr | An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors |
title_full_unstemmed | An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors |
title_short | An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors |
title_sort | investigation of molecular docking and molecular dynamic simulation on imidazopyridines as b-raf kinase inhibitors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661884/ https://www.ncbi.nlm.nih.gov/pubmed/26580609 http://dx.doi.org/10.3390/ijms161126026 |
work_keys_str_mv | AT xiehuiding aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT liyupeng aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT yufang aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT xiexiaoguang aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT qiukaixiong aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT fujijun aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT xiehuiding investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT liyupeng investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT yufang investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT xiexiaoguang investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT qiukaixiong investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors AT fujijun investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors |